6,543 followers
New research: Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study: Background Previous analysis of the study (NCT02577393) had… https://t.co/RAcpE48W